PLAMOTAMAB
UNII 5ENX424FNF

Substance Identification & Data

This profile provides standardized clinical and technical data for Plamotamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5ENX424FNF.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2138442-31-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

5ENX424FNF

CAS Registry Number

2138442-31-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PLAMOTAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C130050

National Cancer Institute reference terminology for clinical and research data.

INN ID

11020

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

GH-170

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Plamotamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PLAMOTAMAB

Common Names & Synonyms

ANTI-CD20/CD3 MONOCLONAL ANTIBODY XMAB13676

PLAMOTAMAB [INN]

PLAMOTAMAB [USAN]

PLAMOTAMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD3 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL XMAB13676 .GAMMA.1-CHAIN), (265->230'),(268->233')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL XMAB13676 .GAMMA.1-CHAIN) DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL XMAB13676 .KAPPA.-CHAIN

SYS